tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kristen Kluska, 217 are a BUY (90.42%), 23 are a HOLD (9.58%).
Analyst Kristen Kluska, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 39.04% that have a potential upside of 39.24% achieved within 114 days.
Kristen Kluska’s has documented 466 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on FOLD, Amicus Therapeutics at 19-Dec-2025.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $4 was fulfilled within 2 days with a profit of $1.19 (42.35%) receiving and performance score of 211.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 13-Oct-2025
$24
$0.24 (1.01%)
$21
1 months 21 days ago
(17-Dec-2025)
2/3 (66.67%)
$-1.77 (-6.87%)
36
Buy Since 28-Apr-2025
$62
$38.24 (160.94%)
$62
4 months 21 days ago
(17-Sep-2025)
0/3 (0%)
$37.54 (153.48%)
Buy Since 07-Oct-2024
$48
$24.24 (102.02%)
$70
5 months 18 days ago
(20-Aug-2025)
0/2 (0%)
$27.11 (129.78%)
Buy Since 03-Jun-2014
$42
$18.24 (76.77%)
$50
5 months 18 days ago
(20-Aug-2025)
6/30 (20%)
$21.11 (101.05%)
256
Buy Since 25-Sep-2024
$38
$14.24 (59.93%)
$44
5 months 18 days ago
(20-Aug-2025)
4/6 (66.67%)
$17.11 (81.91%)
165
Which stock is Kristen Kluska is most bullish on?
Which stock is Kristen Kluska is most reserved on?
What Year was the first public recommendation made by Kristen Kluska?
